...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

posted on Mar 30, 2020 12:10PM

What I find frustrating the if we saw omproved eGFR with patients below 60 subgroup.

It was not in this publication and IR won't tell us if/when we will see it,...

 

Share
New Message
Please login to post a reply